Further Information:
The Health Products Regulatory Authority has been notified of a shortage of the following products:
- Dexamethasone Phosphate 4mg/ml Solution for Injection - PA0822/201/001
- Estradot 37.5mcg/24 hours, Transdermal Patch - PA0896/010/001
- Estradot 50mcg/24 hours, Transdermal Patch - PA0896/010/002
- Estradot 75mcg/24 hours, Transdermal Patch - PA0896/010/003
- Estradot 100mcg/24 hours, Transdermal Patch - PA0896/010/004
- Evorel 50mcg per 24 hours Transdermal Patch - PA22668/008/001
- Phenergan 5mg/5ml Oral Solution - PA23180/011/001
- Temodal 5mg Capsules - EU/1/98/096/024
The following shortages have been resolved and supply has resumed to the Irish market:
- Claforan Powder for Solution for Injection 500mg - PA0540/037/002
- Clexane 2,000 IU (20mg) /0.2 mL Solution for Injection in Pre Filled Syringes - PA0540/097/004
- Clexane 10,000 IU (100mg)/1ml Solution for Injection in Pre Filled Syringes - PA0540/097/001
- Metformin Hydrochloride 500mg/5ml Oral Solution - PA23081/008/001
- Ondansetron 2mg/ml Solution for Injection (4ml presentation) - PA1122/004/001
- Strattera 10mg Capsules - PA2276/007/001
- Strattera 25mg Capsules - PA2276/007/002
- Strattera 40mg Capsules - PA2276/007/003
Please see the shortages section of the HPRA website for further information.
The HPRA will be sending weekly updates concerning medicinal product shortages. However, the above webpage will be updated as new information is provided to the HPRA.